Clinical trial
Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial
NCT00110448 is registered in ClinicalTrials.gov with Kumamoto University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial
- Lead sponsor
- Kumamoto University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2002
- Completion date
- April 30, 2008
- Enrollment
- 2,539 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.